Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial tenecteplase after partial reperfusion in mechanical thrombectomy for acute large vessel occlusion
ChiCTR2600117118Phase 4Recruiting
- Sponsor
- Southern Medical University Shenzhen Hospital
- Start
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ischemic stroke and Large-Vessel Ischemic Stroke (LVO) comparing TNK group with Placebo group (2 arms). Primary endpoint: Proportion of patients with mRS 0–1 at 90 ± 7 days. Started Dec 2025; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic strokeLarge-Vessel Ischemic Stroke (LVO)
Beyond the preview
Go deeper on ChiCTR2600117118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117118.